Clinical Trial Update: A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for SNS-101 (anti-VISTA) as monotherapy and in combination with cemiplimab in adults with advanced solid tumors, currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Esophageal Cancer
• Head and Neck Squamous Cell Carcinoma
• Melanoma
• Ovarian Cancer
• Pancreatic Adenocarcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Cemiplimab (cemiplimab)
• SNS-101

Snippet

Sponsor: Sensei Biotherapeutics, Inc. | Conditions: Solid Tumor, Adult, Advanced Solid Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING